Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Artemisia absinthium contains absinthin and thujone compounds that demonstrate anti-inflammatory effects through TNF-alpha suppression. Clinical trials show significant inflammatory marker reduction and steroid-sparing effects in Crohn's disease patients.
Origin & History
Artemisia absinthium, commonly known as wormwood, is a perennial herb native to Europe, Asia, and North Africa, belonging to the Asteraceae family. The aerial parts of the plant are harvested and typically extracted using ethanol or methanol solvents via maceration or percolation methods. It contains bioactive compounds including thujone and absinthin from the sesquiterpene lactone class.
Research Narrative (Provisional)
Human clinical evidence is limited primarily to inflammatory bowel disease, with a controlled trial showing TNF-alpha reduction in Crohn's patients (PMID: 19962291) and a double-blind RCT (n=40) demonstrating steroid-sparing effects (PMID: 17240130). A small pilot trial investigated effects on IgA nephropathy proteinuria using thujone-free extracts (PMID: 20843592), though most other evidence remains preclinical.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
Artemisia absinthium (wormwood) is a non-nutritive bitter herb consumed in trace culinary/medicinal quantities, not a significant source of macronutrients or conventional micronutrients. Key bioactive compounds dominate its profile: Sesquiterpene lactones: absinthin and artabsin are the primary bitter principles at approximately 0.15–0.40% dry weight, responsible for digestive and anti-inflammatory effects. Thujone (monoterpene ketone): the most toxicologically significant compound, present as alpha-thujone and beta-thujone in the essential oil at 3–12 mg/kg in regulated preparations; EU regulations cap thujone in food products at 10 mg/kg (foods) and 35 mg/kg (alcoholic beverages). Essential oil content: 0.2–1.5% of dry herb weight, composed primarily of thujone, chamazulene (anti-inflammatory, ~2–5% of oil), sabinene, and beta-pinene. Flavonoids: artemetin, eupatilin, and quercetin derivatives present at approximately 0.5–1.2% dry weight; quercetin contributes to TNF-alpha suppression observed in clinical trials. Phenolic acids: chlorogenic acid and caffeic acid derivatives at ~0.3–0.8% dry weight. Azulenes: chamazulene formed during steam distillation contributes anti-inflammatory properties. Lignans and coumarins present in minor quantities (<0.1%). Protein content negligible (<1% dry weight). Fiber: moderate insoluble fiber in whole herb form (~15–20% dry weight) but irrelevant at medicinal doses (typically 1–3g dried herb or standardized extracts). Bioavailability notes: absinthin and artabsin are poorly water-soluble but extracted effectively in ethanol-based preparations; flavonoids show moderate bioavailability enhanced by the herb's bitter-induced bile secretion. Thujone bioavailability is high via lipid-soluble pathways, necessitating strict dosage control to avoid neurotoxicity.
Reported Mechanism (Provisional)
Artemisia absinthium's bioactive compounds absinthin and thujone suppress pro-inflammatory cytokines, particularly TNF-alpha, through inhibition of NF-κB pathway activation. The sesquiterpene lactones in the plant modulate T-cell responses and reduce inflammatory mediator production in intestinal tissues.
Clinical Narrative (Provisional)
A controlled trial (PMID: 19962291) demonstrated significant TNF-alpha reduction from 24.5 to 8.0 pg/ml in Crohn's disease patients after 6 weeks of treatment. Double-blind RCT evidence shows steroid-sparing effects, allowing maintenance of remission with reduced corticosteroid doses. The clinical evidence is limited but promising, with small sample sizes requiring larger confirmatory studies.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.